Overview
Osteonecrosis, also known as avascular necrosis (AVN), aseptic necrosis, or bone infarction, is a condition where bone tissue dies because it does not get enough blood supply. When blood flow to a section of bone is reduced or cut off, the bone cells begin to die. Over time, this can cause the bone to weaken and eventually collapse, especially near joints. The most commonly affected area is the hip, but osteonecrosis can also occur in the knee, shoulder, ankle, and wrist. Symptoms often start with joint pain that may be mild at first but gradually worsens over weeks or months. In the early stages, you might only feel pain when putting weight on the affected joint. As the condition progresses, pain can occur even at rest, and the joint may become stiff and lose its range of motion. If the bone collapses, the pain can become severe and disabling. Osteonecrosis can be caused by many factors, including long-term use of corticosteroid medications, excessive alcohol use, trauma or fractures, sickle cell disease, and certain autoimmune conditions. In some cases, no clear cause is found, which is called idiopathic osteonecrosis. Treatment depends on the stage of the disease and ranges from medications and physical therapy in early stages to surgical options such as core decompression, bone grafting, or joint replacement in advanced cases. Early detection and treatment are important to preserve the joint and prevent further bone damage.
Also known as:
Key symptoms:
Joint pain that worsens over timePain in the hip, knee, or shoulder areaPain when bearing weight on the affected jointStiffness in the affected jointReduced range of motionLimping or difficulty walkingPain at rest in advanced stagesGroin pain (when the hip is affected)Joint swellingDifficulty with daily activities like climbing stairsSudden onset of severe pain if bone collapsesPain that spreads to the buttock or thigh
Multifactorial
Caused by a mix of several genes and environmental factors
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsKyunghee University Dental Hospital — NA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS — NA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS — NA
Zhejiang University — PHASE2
The Affiliated Hospital Of Guizhou Medical University — PHASE4
University Hospital, Strasbourg, France
Tanta University — NA
Huazhong University of Science and Technology — PHASE4
MoonLake Immunotherapeutics AG — PHASE3
Mohamed Nasr
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Osteonecrosis.
11 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Osteonecrosis.
Community
No community posts yet. Be the first to share your experience with Osteonecrosis.
Start the conversation →Latest news about Osteonecrosis
Disease timeline:
New recruiting trial: Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
A new clinical trial is recruiting patients for Osteonecrosis
New recruiting trial: The Effects of General Versus Spinal Anesthesia on Postoperative Myocardial Injury
A new clinical trial is recruiting patients for Osteonecrosis
New recruiting trial: Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.
A new clinical trial is recruiting patients for Osteonecrosis
New recruiting trial: Monitoring of the Bone Free Flaps With Microdialysis
A new clinical trial is recruiting patients for Osteonecrosis
New recruiting trial: Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
A new clinical trial is recruiting patients for Osteonecrosis
New recruiting trial: Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
A new clinical trial is recruiting patients for Osteonecrosis
New recruiting trial: Immunological Parameters Between MRONJ Stages
A new clinical trial is recruiting patients for Osteonecrosis
New recruiting trial: Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective Study
A new clinical trial is recruiting patients for Osteonecrosis
New recruiting trial: Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)
A new clinical trial is recruiting patients for Osteonecrosis
New recruiting trial: Study of the Clinical and Radiographic Results of a Fixed Polyethylene Posteriorly Stabilized Cemented Total Knee Prosthesis With a Minimum Follow-up of 1 Year.
A new clinical trial is recruiting patients for Osteonecrosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage is my osteonecrosis, and what does that mean for my treatment options?,What caused my osteonecrosis, and can we address the underlying cause to prevent it from getting worse?,Am I a candidate for joint-preserving surgery like core decompression, or will I likely need a joint replacement?,Are there medications that could slow down the progression of my bone damage?,How often should I have imaging done to monitor the condition?,What activities should I avoid, and what exercises are safe for me?,Are my other joints at risk for developing osteonecrosis too?
Common questions about Osteonecrosis
What is Osteonecrosis?
Osteonecrosis, also known as avascular necrosis (AVN), aseptic necrosis, or bone infarction, is a condition where bone tissue dies because it does not get enough blood supply. When blood flow to a section of bone is reduced or cut off, the bone cells begin to die. Over time, this can cause the bone to weaken and eventually collapse, especially near joints. The most commonly affected area is the hip, but osteonecrosis can also occur in the knee, shoulder, ankle, and wrist. Symptoms often start with joint pain that may be mild at first but gradually worsens over weeks or months. In the early st
How is Osteonecrosis inherited?
Osteonecrosis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Osteonecrosis typically begin?
Typical onset of Osteonecrosis is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Osteonecrosis?
Yes — 11 recruiting clinical trials are currently listed for Osteonecrosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Osteonecrosis?
25 specialists and care centers treating Osteonecrosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.